ATE252913T1 - Vorbeugung einer krankheit mit diabetes charakter - Google Patents

Vorbeugung einer krankheit mit diabetes charakter

Info

Publication number: ATE252913T1
Authority: AT; Austria
Prior art keywords: diabetes; prevention; type disease; type; disease
Prior art date: 1995-06-30

Application number

AT96921919T

Other languages

English (en)

Inventor

Thomas Dyrberg

Anne Worsaae

Original Assignee

Novo Nordisk As

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1995-06-30

Filing date

1996-07-01

Publication date

2003-11-15

1996-07-01 Application filed by Novo Nordisk As filed Critical Novo Nordisk As

2003-11-15 Application granted granted Critical

2003-11-15 Publication of ATE252913T1 publication Critical patent/ATE252913T1/de

Links

206010012601 diabetes mellitus Diseases 0.000 title abstract 2
201000010099 disease Diseases 0.000 title 1
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title 1
230000002265 prevention Effects 0.000 title 1
241000124008 Mammalia Species 0.000 abstract 1
206010067584 Type 1 diabetes mellitus Diseases 0.000 abstract 1
230000002218 hypoglycaemic effect Effects 0.000 abstract 1
NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical class N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/28—Insulins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Diabetes (AREA)
Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Bioinformatics & Cheminformatics (AREA)
Public Health (AREA)
Endocrinology (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Engineering & Computer Science (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Obesity (AREA)
Hematology (AREA)
Emergency Medicine (AREA)
Zoology (AREA)
Gastroenterology & Hepatology (AREA)
Immunology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Epidemiology (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicines Containing Plant Substances (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Peptides Or Proteins (AREA)

AT96921919T 1995-06-30 1996-07-01 Vorbeugung einer krankheit mit diabetes charakter ATE252913T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
DK76595		1995-06-30
PCT/DK1996/000297 WO1997002043A1 (en)	1995-06-30	1996-07-01	Prevention of a disease having the characteristics of diabetes

Publications (1)

Publication Number	Publication Date
ATE252913T1 true ATE252913T1 (de)	2003-11-15

Family

ID=8097303

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT96921919T ATE252913T1 (de)	1995-06-30	1996-07-01	Vorbeugung einer krankheit mit diabetes charakter

Country Status (7)

Country	Link
US (3)	US6274549B1 (de)
EP (1)	EP0835129B1 (de)
JP (1)	JPH11509195A (de)
AT (1)	ATE252913T1 (de)
AU (1)	AU6299596A (de)
DE (1)	DE69630527T2 (de)
WO (1)	WO1997002043A1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1999042482A1 (en) *	1998-02-23	1999-08-26	Neurocrine Biosciences, Inc.	Methods for treatment of diabetes using peptide analogues of insulin
US6562942B1 (en)	1999-02-23	2003-05-13	Neurocrine Biosciences, Inc.	Methods for treatment of diabetes using peptide analogues of insulin
AU781405B2 (en) *	1998-02-23	2005-05-19	Neurocrine Biosciences, Inc.	Methods for treatment of diabetes using peptide analogues of insulin
JPH11353404A (ja) *	1998-06-11	1999-12-24	Hitachi Ltd	電子カルテシステム
ES2642214T3 (es)	2004-01-21	2017-11-15	Novo Nordisk Health Care Ag	Conjugación de péptidos mediante transglutaminasa
RU2527893C2 (ru)	2004-07-19	2014-09-10	Биокон Лимитед	Инсулин-олигомерные конъюгаты, их препараты и применения
RU2453332C2 (ru)	2007-10-16	2012-06-20	Байокон Лимитид	Твердая фармацевтическая композиция (варианты) и способ контроля концентрации глюкозы с ее помощью, способ получения твердой фармацевтической композиции (варианты), таблетка (варианты) и способ получения амфорных частиц
HUE032284T2 (en)	2008-03-18	2017-09-28	Novo Nordisk As	Protease-stabilized, acylated insulin analogues
CA3178035A1 (en)	2012-12-24	2014-07-03	Neurogastrx, Inc.	Methods for treating gi tract disorders
US9844554B2 (en)	2014-06-24	2017-12-19	Neurogastrx, Inc.	Prodrugs of metopimazine
PE20210857A1 (es)	2016-12-16	2021-05-18	Novo Nordisk As	Composiciones farmaceuticas que contienen insulina
US10836757B1 (en)	2020-04-02	2020-11-17	Neurogastrx, Inc.	Polymorphic forms of metopimazine

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
IL99699A (en)	1990-10-10	2002-04-21	Autoimmune Inc	Drug with the option of oral, intra-intestinal, or inhaled dosing for suppression of autoimmune response associated with type I diabetes
US5422339A (en) *	1991-03-19	1995-06-06	Joslin Diabetes Center, Inc.	Peptides having insulin autoantibody but not insulin receptor binding capacity
US5891435A (en) *	1993-04-16	1999-04-06	Research Corporation Technologies, Inc.	Methods and compositions for delaying or preventing the onset of autoimmune disease
US5725860A (en) *	1994-03-07	1998-03-10	Auckland Uniservices Limited	Method for reducing the risk of developing diabetes
US5474978A (en) *	1994-06-16	1995-12-12	Eli Lilly And Company	Insulin analog formulations
US5461031A (en) *	1994-06-16	1995-10-24	Eli Lilly And Company	Monomeric insulin analog formulations
WO1997009061A1 (en)	1995-09-06	1997-03-13	Alexion Pharmaceuticals, Inc.	Treatment of diabetes via administration of hormonally ineffective insulin

1996
- 1996-07-01 EP EP96921919A patent/EP0835129B1/de not_active Expired - Lifetime
- 1996-07-01 AT AT96921919T patent/ATE252913T1/de not_active IP Right Cessation
- 1996-07-01 US US09/319,138 patent/US6274549B1/en not_active Expired - Fee Related
- 1996-07-01 DE DE69630527T patent/DE69630527T2/de not_active Expired - Fee Related
- 1996-07-01 WO PCT/DK1996/000297 patent/WO1997002043A1/en not_active Ceased
- 1996-07-01 AU AU62995/96A patent/AU6299596A/en not_active Abandoned
- 1996-07-01 JP JP9504729A patent/JPH11509195A/ja active Pending
2001
- 2001-05-02 US US09/847,623 patent/US20010021696A1/en not_active Abandoned
- 2001-06-01 US US09/872,923 patent/US20010041669A1/en not_active Abandoned

Also Published As

Publication number	Publication date
AU6299596A (en)	1997-02-05
US20010021696A1 (en)	2001-09-13
DE69630527T2 (de)	2004-08-05
WO1997002043A1 (en)	1997-01-23
JPH11509195A (ja)	1999-08-17
US20010041669A1 (en)	2001-11-15
EP0835129B1 (de)	2003-10-29
EP0835129A1 (de)	1998-04-15
DE69630527D1 (de)	2003-12-04
US6274549B1 (en)	2001-08-14

Similar Documents

Publication	Publication Date	Title
ATE252913T1 (de)	2003-11-15	Vorbeugung einer krankheit mit diabetes charakter
DE10199020I2 (de)	2004-05-06	Galanthamin oder dessen Analoge zur Behandlung derAlzheimerschen Krankheit.
FI904414A7 (fi)	1990-09-07	Tiatsolidiinidioni-hypoglykeemisesti vaikuttavat aineet
GB2267441B (en)	1995-05-17	Bandage
SE9500639D0 (sv)	1995-02-21	Assistansbordspåse
TR200000134T2 (tr)	2000-09-21	Tiazolidinedion, ensülin salgılatıcısı ve biguanid ile diabetin (şeker hastalığının) tedavisi.
ATE258797T1 (de)	2004-02-15	Verwendung von amifostin
BR9810444A (pt)	2000-09-05	Tratamento de diabete com rosiglitazona e insulina
KR920700625A (ko)	1992-08-10	고혈압 치료를 위한 신장에 선택적인 프로드러그(Prodrug)
DE69116224D1 (de)	1996-02-22	Behandlung von intraokularem Druck mit einer synergischen Kombination
DE69106777D1 (de)	1995-03-02	Behandlung von intraokularem Druck mit einer ophthalmischen synergistischen Kombination.
DE68904794D1 (de)	1993-03-25	Oesenteil fuer einen haken-oesen-verschluss.
ATE69542T1 (de)	1991-12-15	Kuenstlicher augenbrauenkoerper.
ATE289819T1 (de)	2005-03-15	Gedächnissverbesserung durch verabreichung von delta-5-androsten-3-beta-ol-7,17-dion und 3-beta- estern desselben
TR200000135T2 (tr)	2000-05-22	Tiazolidinedion ve sülfonilüre ile diabet tedavisi.
DE69100171D1 (de)	1993-08-19	Synergistische kombination zur ophthalmischen verwendung.
PT869785E (pt)	2002-12-31	4-hidroxicumarina-3-carboxamidas para o tratamento de diabetes mellitus nao insulinodependente
BR9713349A (pt)	2000-05-09	Método e dispositivo para adaptar uma estrutura de ponte para ajustar elementos de ancoragem em uma mandìbula de paciente.
IT9048106A0 (it)	1990-07-03	Associazione medicamentosa per il trattamento dell'ipertensione e dell'insufficienza cardiaca congestiva. (caso 100-7516)
BR9703451C1 (pt)	2001-12-18	Composto natural para o tratamento de diabete ecâncer etc
DE69611407D1 (de)	2001-02-08	Alternative Kristallform von Tazofelon ((+,-)-5-((3,5-bis(1,1-dimethylethyl)-4-hydroxyphenyl)methyl)-4-thiazolidinon)
DE69101077D1 (de)	1994-03-10	System und Verfahren zum Zusammenbau einer Orthese.
IT8603418A1 (it)	1987-11-16	Calzatura anatomica per la prevenzione e la correzione dell'alluce valgo.
BR9401034C1 (pt)	2000-05-23	Dispositivo de desarme automático para hastes subsoladoras
IT8125850A0 (it)	1981-12-24	Macchina per l'esecuzione contemporanea della scavatura edella cadenzatura su tacchi per scarpe in genere.

Legal Events

Date	Code	Title	Description
2004-04-15	RER	Ceased as to paragraph 5 lit. 3 law introducing patent treaties